Survey of Public Assay Data: Opportunities and Challenges to Understanding Antimicrobial Resistance

Abstract

ABSTRACTComputational learning methods allow researchers to make predictions, draw inferences, and automate generation of mathematical models. These models are crucial to solving real world problems, such as antimicrobial resistance, pathogen detection, and protein evolution. Machine learning methods depend upon ground truth data to achieve specificity and sensitivity. Since the data is limited in this case, as we will show during the course of this paper, and as the size of available data increases super-linearly, it is of paramount importance to understand the distribution of ground truth data and the analyses it is suited and where it may have limitations that bias downstream learning methods. In this paper, we focus on training data required to model antimicrobial resistance (AR). We report an analysis of bacterial biochemical assay data associated with whole genome sequencing (WGS) from the National Center for Biotechnology Information (NCBI), and discuss important implications when making use of assay data, utilizing genetic features as training data for machine learning models. Complete discussion of machine learning model implementation is outside the scope of this paper and the subject to a later publication. The antimicrobial assay data was obtained from NCBI BioSample, which contains descriptive information about the physical biological specimen from which experimental data is obtained and the results of those experiments themselves.[1] Assay data includes minimum inhibitory concentrations (MIC) of antibiotics, links to associated microbial WGS data, and treatment of a particular microorganism with antibiotics. We observe that there is minimal microbial data available for many antibiotics and for targeted taxonomic groups. The antibiotics with the highest number of assays have less than 1500 measurements each. Corresponding bias in available assays makes machine learning problematic for some important microbes and for building more advanced models that can work across microbial genera. In this study we focus, therefore, on the antibiotic with most assay data (tetracycline) and the corresponding genus with the most available sequence (Acinetobacter with 14000 measurements across 49 antibiotic compounds). Using this data for training and testing, we observed contradictions in the distribution of assay outcomes and report methods to identify and resolve such conflicts. Per antibiotic, we find that there can be up to 30% of (resolvable) conflicting measurements. As more data becomes available, automated training data curation will be an important part of creating useful machine learning models to predict antibiotic resistance. CCS CONCEPTS* Applied computing [->] Computational biology; Computational genomics; Bioinformatics;